Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06305234
Status:
RECRUITING
Last Update Posted:
2024-03-12
First Post:
2024-01-30
Brief Title:
A Long Term Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU PALisade
Sponsor:
Organization:
BioMarin Pharmaceutical
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
A small blood sample may be kept to be used only in a health authority request
Enrollment Count:
200
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 104561 |
Who Masked List: